TERF1 and glioblastoma: We analyzed telomeres length, telomerase activity and the expression levels of TRF1, TRF2, h-TERT and TANKS-PARP complex in tumor samples obtained in vivo, investigating the presence of a specific genes expression profile during the different stages of tumor progression, from low grade astrocytomas to glioblastoma.